Literature DB >> 6456877

Spontaneous suppressor cell function in inflammatory bowel disease.

R M Victorino, H J Hodgson.   

Abstract

We investigated suppressor cell activity in the peripheral blood of 39 patients with inflammatory bowel disease (30 Crohn's disease and 9 ulcerative colitis) by the short-lived suppressor cell assay. There was a significant decrease in the suppressor cell activity in patients with inflammatory bowel disease (IBD), compared to 26 healthy subjects studied simultaneously. Five other patients with acute bacterial infections had normal suppressor activity. A group of 14 IBD patients was also investigated for concanavalin A-induced suppressor cell activity and decreased suppressor function was confirmed. A significant positive correlation was found between the two assays. A defect in suppressor cell activity may permit the expression or maintenance of immunologically mediated damage to the gut in IBD.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6456877     DOI: 10.1007/bf01309612

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  38 in total

1.  A study of the cellular infiltrate of the proximal jejunal mucosa in ulcerative colitis and Crohn's disease.

Authors:  R Ferguson; R N Allan; W T Cooke
Journal:  Gut       Date:  1975-03       Impact factor: 23.059

2.  Cortisone in ulcerative colitis; final report on a therapeutic trial.

Authors:  S C TRUELOVE; L J WITTS
Journal:  Br Med J       Date:  1955-10-29

3.  Suppression of autoimmune hemolytic anemia in New Zealand (NZB) mice by syngeneic young thymocytes.

Authors:  M E Gershwin; A D Steinberg
Journal:  Clin Immunol Immunopathol       Date:  1975-05

4.  Decreased suppressor cell activity in inflammatory bowel disease.

Authors:  H J Hodgson; J R Wands; K J Isselbacher
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

5.  Alteration in suppressor cell activity in chronic active hepatitis.

Authors:  H J Hodgson; J R Wands; K J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

6.  Escherichia Coli O:14 and colon hemagglutinating antibodies in inflammatory bowel disease.

Authors:  W R Thayer; M Brown; M H Sangree; J Katz; T Hersh
Journal:  Gastroenterology       Date:  1969-09       Impact factor: 22.682

7.  Direct evidence for loss of human suppressor cells during active autoimmune disease.

Authors:  A J Strelkauskas; R T Callery; J McDowell; Y Borel; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

8.  Isolation and characterization of colonic tissue-bound antibodies from patients with idiopathic ulcerative colitis.

Authors:  K M Das; R Dubin; T Nagai
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

9.  Short-term course and prognosis of Crohn's disease.

Authors:  F T De Dombal; I L Burton; S E Clamp; J C Goligher
Journal:  Gut       Date:  1974-06       Impact factor: 23.059

10.  Immunological studies in ulcerative colitis. IV. Origin of autoantibodies.

Authors:  R Lagercrantz; S Hammarström; P Perlmann; B E Gustafsson
Journal:  J Exp Med       Date:  1968-12-01       Impact factor: 14.307

View more
  9 in total

1.  Antigen induced suppression in peripheral blood and lamina propria mononuclear cells in inflammatory bowel disease.

Authors:  H R Dalton; P Hoang; D P Jewell
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

2.  Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens.

Authors:  F Pallone; S Fais; O Squarcia; L Biancone; P Pozzilli; M Boirivant
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

3.  Immunological studies on Crohn's disease. V. Enumeration of circulating lymphocytes subsets using monoclonal antibodies.

Authors:  N Okabe; K Fujita; M Yamasaki; T Yao; S Tsuru
Journal:  Gastroenterol Jpn       Date:  1985-10

4.  Abnormalities of B-cell activation and immunoregulation in patients with Crohn's disease.

Authors:  G Sieber; F Herrmann; M Zeitz; H Teichmann; H Rühl
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

5.  Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques.

Authors:  W S Selby; G Janossy; M Bofill; D P Jewell
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

6.  Pokeweed mitogen stimulated immunoglobulin production by peripheral blood lymphocytes in vitro: evidence for disordered immunoregulation in patients with ulcerative colitis and Crohn's disease.

Authors:  V A Danis; R V Heatley
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

7.  In vitro immunoglobulin secretion by normal human gastrointestinal mucosal tissues, and alterations in patients with inflammatory bowel disease.

Authors:  V A Danis; A D Harries; R V Heatley
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

8.  Spontaneous suppressor cell activity in the peripheral blood of patients with malignant and chronic inflammatory bowel diseases.

Authors:  K Doldi; B Manger; B Koch; J Riemann; P Hermanek; J R Kalden
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

9.  T lymphocyte subsets in inflammatory bowel disease: peripheral blood.

Authors:  W S Selby; D P Jewell
Journal:  Gut       Date:  1983-02       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.